{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:17:39Z","timestamp":1788419859837,"version":"build-2803163510"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Liposomal drug delivery systems have evolved into clinically validated\nplatforms across diverse therapeutic areas. This review aims to provide a translational perspective by\nlinking fundamental formulation principles with clinically approved products and industrial manufacturing\nstrategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A structured narrative review was undertaken to examine liposomal formulations approved\nby major regulatory authorities across a range of clinical applications, including oncology, infectious\ndiseases, vaccination, pain management, gene therapy, and regenerative medicine. The analysis focused\non key formulation parameters, manufacturing techniques, and characterization methods. Relevant\nstudies were identified through comprehensive searches of major scientific databases, including\nPubMed, Scopus, Web of Science, and ScienceDirect, as well as patent platforms such as Google\nPatents and Espacenet. Study selection was guided by predefined inclusion and exclusion criteria,\nprioritizing translational relevance, formulation strategies, manufacturing approaches, and clinically\napproved liposomal systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Lipid composition, vesicle size, surface functionalization, and release characteristics were\nidentified as critical determinants of pharmacokinetics, therapeutic efficacy, and safety. Scalable and\nenvironmentally conscious manufacturing approaches, including supercritical fluid technologies,\nmicrofluidic systems, and solvent-reduction strategies, demonstrated strong alignment with regulatory\nand sustainability expectations. In characterization, emerging artificial intelligence-based tools\nshowed potential for improved vesicle identification, size distribution analysis, and morphological\nassessment compared with conventional techniques such as dynamic light scattering and electron\nmicroscopy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The integration of advanced formulation design, scalable manufacturing, and data-driven\ncharacterization enhances the translational potential of liposomal systems. However, challenges remain\nregarding standardization, regulatory acceptance of novel analytical tools, and reproducibility at\nindustrial scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Liposomal drug delivery systems represent a mature yet evolving platform. Bridging\nlaboratory innovations with clinically and industrially viable solutions requires coordinated advances\nin formulation, manufacturing, and characterization. This review provides a practical framework for\nthe development of next-generation liposomal systems with translational relevance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115672018479857260820060310","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:36:59Z","timestamp":1788187019000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Translational Liposomal Drug Delivery Systems: Clinically Approved Formulations, Scalable Manufacturing Strategies, and Emerging Characterization Approaches"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1547-0817","authenticated-orcid":true,"given":"Umay Merve G\u00fcven","family":"B\u00f6lgen","sequence":"first","affiliation":[{"name":"\u00c7ukurova University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0881-0644","authenticated-orcid":true,"given":"Tilbe","family":"\u00c7evikelli","sequence":"additional","affiliation":[{"name":"Bah\u00e7e\u015fehir University, Faculty of Pharmacy, Department of Pharmaceutical Technology, \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9596-0538","authenticated-orcid":true,"given":"A. Alper","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[{"name":"Anadolu University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Eski\u015fehir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115672018479857260820060310","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/257767\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115672018479857260820060310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:59:26Z","timestamp":1788418766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/257767\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115672018479857260820060310","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2026-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}